IBEX Limited
DE ˙ DB
25,80 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityDE:IB7 / IBEX Limited
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership664,667 shares
Ownership 3.64%
Ameriprise Financial Inc ownership in IB7 / IBEX Limited

2023-02-14 - Ameriprise Financial Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 664,667 shares of IBEX Limited (DE:IB7). This represents 3.64 percent ownership of the company. In their previous filing dated 2022-02-14 , Ameriprise Financial Inc had reported owning 970,088 shares, indicating a decrease of -31.48 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2023-02-14 2023-02-14 13G/A 970,088 664,667 -31.48 3.64 -30.67
2022-02-14 2022-02-14 13G 970,088 5.25

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IBEX COM G4690M101 337,503 -777 -0.23 9,052 -29.92 0.0004
2026-02-17 2025-12-31 13F IBEX COM G4690M101 338,280 -1,246 -0.37 12,916 -6.12 0.0029
2025-11-14 2025-09-30 13F IBEX COM G4690M101 339,526 -106,421 -23.86 13,758 6.01 0.0032
2025-08-14 2025-06-30 13F IBEX COM G4690M101 445,947 -69,168 -13.43 12,977 3.46 0.0032
2025-05-14 2025-03-31 13F IBEX COM G4690M101 515,115 4,713 0.92 12,543 14.36 0.0034
2025-02-14 2024-12-31 13F IBEX COM G4690M101 510,402 4,777 0.94 10,969 8.57 0.0028
2024-11-14 2024-09-30 13F IBEX COM G4690M101 505,625 12,770 2.59 10,102 26.69 0.0026
2024-08-14 2024-06-30 13F IBEX COM G4690M101 492,855 76,647 18.42 7,974 24.17 0.0022
2024-05-15 2024-03-31 13F IBEX COM G4690M101 416,208 66,172 18.90 6,422 -3.49 0.0018
2024-02-14 2023-12-31 13F IBEX COM G4690M101 350,036 3,959 1.14 6,654 24.47 0.0020
2023-11-14 2023-09-30 13F IBEX COM G4690M101 346,077 79,970 30.05 5,347 -5.36 0.0018
2023-08-14 2023-06-30 13F IBEX COM G4690M101 266,107 -26,100 -8.93 5,649 -20.76 0.0018
2023-05-22 2023-03-31 13F/A-1 IBEX COM G4690M101 292,207 -372,460 -56.04 7,130 -56.84 0.0023
2023-05-15 2023-03-31 13F HORIZON THERAPEUTICS OPT G4690M101 292,207 -372,460 7,130 0.0004
2023-02-14 2022-12-31 13F IBEX COM G4690M101 664,667 -227,585 -25.51 16,517 -0.31 0.0057
2022-11-14 2022-09-30 13F IBEX COM G4690M101 892,252 -97,956 -9.89 16,568 -0.82 0.0061
2022-08-15 2022-06-30 13F IBEX COM G4690M101 990,208 -14,145 -1.41 16,705 4.34 0.0058
2022-05-16 2022-03-31 13F IBEX COM G4690M101 1,004,353 34,265 3.53 16,010 28.03 0.0047
2022-02-14 2021-12-31 13F IBEX COM G4690M101 970,088 129,394 15.39 12,505 -12.50 0.0035
2021-11-15 2021-09-30 13F IBEX COM G4690M101 840,694 75,036 9.80 14,292 -4.38 0.0046
2021-08-16 2021-06-30 13F IBEX COM G4690M101 765,658 -17,023 -2.17 14,946 -13.20 0.0046
2021-05-17 2021-03-31 13F IBEX COM G4690M101 782,681 29,729 3.95 17,218 22.29 0.0057
2021-02-12 2020-12-31 13F IBEX COM G4690M101 752,952 -327,170 -30.29 14,080 -15.24 0.0050
2020-11-16 2020-09-30 13F IBEX COM G4690M101 1,080,122 1,080,122 16,611 0.0068
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.